Aimei Health Technology Statistics
Total Valuation
AFJK has a market cap or net worth of $55.10 million. The enterprise value is $57.36 million.
Important Dates
The last earnings date was Tuesday, November 18, 2025, after market close.
| Earnings Date | Nov 18, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AFJK has 6.12 million shares outstanding. The number of shares has decreased by -11.54% in one year.
| Current Share Class | 6.12M |
| Shares Outstanding | 6.12M |
| Shares Change (YoY) | -11.54% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 28.18% |
| Owned by Institutions (%) | 56.71% |
| Float | 4.40M |
Valuation Ratios
The trailing PE ratio is 46.29.
| PE Ratio | 46.29 |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 40.80 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.01
| Current Ratio | 0.01 |
| Quick Ratio | 0.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -1.04% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -2.31% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -15.08% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -15.08% |
| 50-Day Moving Average | 11.43 |
| 200-Day Moving Average | 10.88 |
| Relative Strength Index (RSI) | 40.66 |
| Average Volume (20 Days) | 32,914 |
Short Selling Information
The latest short interest is 5,134, so 0.08% of the outstanding shares have been sold short.
| Short Interest | 5,134 |
| Short Previous Month | 1,231 |
| Short % of Shares Out | 0.08% |
| Short % of Float | 0.12% |
| Short Ratio (days to cover) | 0.21 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -987,191 |
| Pretax Income | 1.41M |
| Net Income | 1.41M |
| EBITDA | n/a |
| EBIT | -987,191 |
| Earnings Per Share (EPS) | $0.20 |
Full Income StatementBalance Sheet
The company has $2,979 in cash and $1.66 million in debt, giving a net cash position of -$1.65 million or -$0.27 per share.
| Cash & Cash Equivalents | 2,979 |
| Total Debt | 1.66M |
| Net Cash | -1.65M |
| Net Cash Per Share | -$0.27 |
| Equity (Book Value) | -3.44M |
| Book Value Per Share | -0.56 |
| Working Capital | -2.75M |
Full Balance SheetCash Flow
| Operating Cash Flow | -716,999 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
